Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT03875313
Brief Title: Study of CB-839 (Telaglenastat) in Combination With Talazoparib in Patients With Solid Tumors

First Submitted : March 5, 2019
First Submitted that Met QC Criteria : March 13, 2019
First Posted : March 14, 2019

Last Update Submitted that Met QC Criteria : August 16, 2021
Last Update Posted : August 18, 2021